Downregulation of miR-526 a by Enterovirus Inhibits RIGI-Dependent Innate 1 Immune Response 2
Changzhi Xu,Xiang He,Zirui Zhen,Zhe Zhang,Congwen Wei,Kai,Guan,Lihua Hou,Buchang Zhang,Lin Zhu,Yuan Cao,Yanhong Zhang,Ye Cao,Shengli Ma,Penghao Wang,Pingping Zhang,Quanbin Xu,Youguo Ling,Xiao Yang,Hui Zhong
2014-01-01
Abstract:18 Retinoic acid-inducible gene I (RIG-I) is an intracellular RNA virus sensor that 19 induces type I interferon-mediated host protective innate immunity against viral 20 infection. Although cylindromatosis (CYLD) has been shown to negatively 21 regulate innate antiviral response by removing K-63-linked polyubiquitin from 22 RIG-I, the regulation of its expression and the underlying regulatory 23 mechanisms are still incompletely understood. Here we show that RIG-I 24 activity is regulated by miR-526a-mediated inhibition of CYLD expression. We 25 found that viral infection specifically upregulates miR-526a expression in 26 macrophages via IRF-dependent mechanisms. In turn, miR-526a positively 27 regulates virus-triggered type I Interferon (IFN-I) production, thus suppressing 28 viral replication, the underlying mechanism of which is the enhancement of 29 RIG-I K63-linked ubiquitination by miR-526a via suppressing the expression of 30 CYLD. Remarkably, viral-induced miR-526a upregulation and CYLD 31 downregulation are blocked by enterovirus 71 (EV71) 3C protein, while ectopic 32 miR-526a expression inhibits the replication of EV71 virus. The collective 33 results of this study suggest a novel mechanism of the regulation of RIG-I 34 activity during RNA virus infection by miR-526a and propose a novel 35 mechanism for the evasion of innate immune response controlled by EV71. 36 37 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom Importance 38 RNA virus infection upregulates the expression of miR-526a in macrophages 39 through IRF-dependent pathways. In turn, miR-526a positively regulates 40 virus-triggered type I IFN production and inhibits viral replication, the 41 underlying mechanism of which is the enhancement of RIG-I K-63 42 ubiquitination by miR-526a via suppressing the expression of CYLD. 43 Remarkably, viral-induced miR-526a upregulation and CYLD downregulation 44 are blocked by enterovirus 71 (EV71) 3C protein, cells with overexpressed 45 miR-526a were highly resistant to EV71 infection. The collective results of this 46 study suggest a novel mechanism of the regulation of RIG-I activity during 47 RNA virus infection by miR-526a and propose a novel mechanism for the 48 evasion of innate immune response controlled by EV71. 49 50 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom Introduction 51 EV71 is a positive-stranded RNA virus, which belongs to the picornavirus 52 family (1) and is the causative agent of hand-foot-and-mouth disease (HFMD) 53 in young children and infants. The genome of EV71 is approximately 7.5 kb in 54 length and contains a single open reading frame encoding a polyprotein 55 precursor, which is processed into structural (VP1, VP2, VP3, and VP4) and 56 nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) during viral infection 57 (2). Despite the protective role of IFN-I on EV71 infection, EV71 inoculation is 58 unable to elicit their production. Most members of the picornavirus family, 59 including poliovirus, rhinovirus, echovirus, and encephalomyocarditis virus, 60 use strategies to inhibit IFN-I induction by interfering with melanoma 61 differentiation-associated gene 5 (MDA-5) and RIG-I (3-5) or by restricting 62 IFN-secretion through repressing the cellular secretory pathway (6). Recent 63 studies revealed that the 3C protease of EV71 associated with RIG-I and 64 cleaved TRIF (TIR-domain-containing adapter-inducing interferon-β) and 65 IRF7 ( interferon regulatory factor 7) (7, 8); moreover, EV71 inhibited 66 IFN-I-induced ISGs (interferon stimulating genes) in host cells by reducing 67 IFNAR1 (type I interferon receptor 1) levels in host cells (9). However, 68 additional work is required to understand the mechanisms for EV71 to escape 69 from innate antiviral responses. 70 IFN-I, as the first line of host immune response, is critical in mediating 71 antiviral defense. The host senses viral and bacterial pathogen invasion by 72 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom recognition of pathogen-associated molecular patterns with pattern recognition 73 receptors, including membrane-bound TLRs (Toll-like receptors) (10, 11) and 74 cytosolic sensory molecules, such as the multi-domain containing NOD 75 (nucleotide-binding oligomerization domain) proteins, RIG-I, and MDA-5 76 helicases (12-14). Both RIG-I and MDA-5 contain caspase recruitment 77 domains (CARDs) that interact with the CARD domain-containing protein 78 mitochondrial antiviral signaling (MAVS) upon binding to uncapped RNA, 79 resulting in MAVS association with IκB kinase (IKK) proteins. While MAVS 80 association with IKKα/β activates NF-κB (nuclear factor-κ-gene binding), its 81 association with TBK1 (TANK-binding kinase 1 ) as well as IKKε leads to the 82 activation of IRF-3/IRF-7; coordinated activation of NF-κB and IRF pathways 83 further results in the assembly of a multi-protein enhancer complex that drives 84 the expression of IFN-β (interferon-β) and the IFN-mediated antiviral immunity 85 (15-19). 86 RIG-I signaling is negatively regulated at multiple levels. Previous reports 87 showed that the ubiquitination status of RIG-I is controlled by CYLD, a tumor 88 suppressor originally identified as a genetic defect in familial cylindromatosis 89 (20). Indeed, CYLD was shown to interact with the CARDs of RIG-I and to 90 remove K63-linked polyubiquitin chains from RIG-I, which inhibits downstream 91 signaling. DC (Dendritic cells) lacking CYLD constitutively polyubiquitinates 92 RIG-I and shows enhanced activity of TBK1 and IKKε, suggesting that CYLD 93 regulates basal RIG-I activity by modulating its K63-polyubiquitin status (21). 94 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom CYLD also acts as a negative regulator of NF-κB and Jun N-terminal kinase 95 signaling pathways by removing Lys 63-linked polyubiquitin from NEMO 96 (nuclear factor-kappaa B essential modulator), IKKε, TRAF2 (TNF receptor 97 associated factor 2) or BCL3 (B-cell CLL/lymphoma3) (22-25). These findings 98 thus establish CYLD as a critical regulator of antiviral innate immune response. 99 MiRNAs, an abundant class of highly conserved noncoding RNA 100 oligonucleotides (18-25 nt long), suppress gene expression by binding to the 101 3’-untranslational region (UTR) of target mRNAs. MiRNAs play key roles in the 102 regulation of diverse biological processes. Recently, a role for miRNAs has 103 been proposed in the regulation of innate immune responses in monocytes 104 and macrophages. Direct roles of miRNAs in innate immune response were 105 discovered in a report that identified miR-146a as a negative feedback 106 regulator in RLR signaling by targeting IL-1R associated kinase (IRAK) 1 and 107 TNF receptor associated factor 6 (TRAF6) (26). Further reports showed that 108 both miR-155 and miR-132 were induced in monocyte cell line treated with the 109 TLR4 (Toll-like receptor 4) ligand lipopolysaccharide (LPS) (27). Given the 110 important roles of the RIG-I signaling pathway in innate antiviral immune 111 response, identifying more miRNAs that can regulate RIG-I-dependent IFN-I 112 production is of vital importance. In fact, many viruses have evolved strategies 113 to interfere with these innate signaling events and hence inhibit IFN-β 114 production. However, to date, there is few report about the regulation of RIG-I 115 signaling pathway by miRNAs, especially during EV71 infection. 116 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom In the present study, we found that miR-526a was significantly 117 upregulated in macrophages upon viral infection in an IRF-dependent manner. 118 Then we demonstrated that miR-526a feedback positively regulated 119 VSV-triggered IRF3 activation by suppressing CYLD expression and 120 subsequent RIGI ubiquitination. Furthermore, we found that miR-526a 121 upregulation was blocked by EV71 3C protease, whereas ectopic miR-526a 122 expression inhibited the replication of EV71. Thus the present study has for the 123 first time demonstrated that miR-526a is a positive feedback regulator of the 124 RIG-I signaling and that EV71 targets miR-526a to suppress RIG-I-dependent 125 IFN-I production. 126 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom Materials and Methods 127 Cell Culture and Transfection 128 293T, Vero, RD, MDCK and THP-1 cells were cultured in DMEM and 129 RPMI1640 (Invitrogen) respectively, supplemented with 10% heat-inactivated 130 fetal bovine serum (FBS, Invitrogen), 100 U/mL penicillin and 100 mg/mL 131 streptomycin. Vectors and Epitope Tagging of Flag-tagged IRF3, IRF7, p65, 132 MDA-5, RIG-I, N-RIG-I, MAVS and TBK1 were expressed by cloning the 133 respective genes into the pcDNA3-Flag vector. MiR-526a expression plasmid 134 was expressed by cloning miR-526a into Pires 2-EGFP vector. siRNA oligos 135 were ordered from GenePharma and transfected with Lipofectamine 2000 136 (Invitrogen) according to the manufacturer’s instructions. The sequences of 137 primers for small interference RNAs used were shown in Table 1. 138 miRNA mimics and inhibitors 139 MiR-526a mimics (dsRNA oligonucleotides) and MiR-526a inhibitors 140 (single-stranded chemically modified oligonucleotides) from GenePharma 141 were used for the overexpression and inhibition of MiR-526a activity 142 respectively. Negative control mimics or inhibitors (GenePharma) were 143 transfected as matched controls. 144 MiR-526a mimics sense: 5’-CUCUAGAGGGAAGCACUUUCUG-3’; 145 anti-sense: 5’-GAAAGUGCUUCCCUCUAGAGUU-3’, 146 MiR-526b mimics sense: 5’-CUCUUGAGGGAAGCACUUUCUGU-3’; 147 anti-sense: 5’-AGAAAGUGCUUCCCUCAAGAGUU-3’, 148 on D ecem er 6, 2017 by gest http/jvi.asm .rg/ D ow nladed fom control mimics sense: 5’-UUCUCCGAACGUGUCACGUTT-3’; 149 anti-sense: 5’-ACGUGACACGUUCGGAGAATT-3’, 150 miR-526a inhibitor 5’-CAGAAAGUGCUUCCCUCUAGAG-3’ (chemically 151 modified by 2’-Ome), 152 control inhibitor 5’-CAGUACUUUUGUGUAGUACAA-3’. 153 Viruses and Viral Plaque Assay 154 The con